|
 |
Anthony Sun is a Director of Paratek Pharmaceuticals. Dr. Sun joined Aisling Capital, Fund I in 2002 and currently serves
as a Partner. Previously, Dr. Sun was an Adjunct Instructor of Medicine at the Hospital of the University of Pennsylvania.
Dr. Sun currently serves as a director of CeNeRx BioPharma, Inc., Dynova Laboratories, Inc., HerbalScience, Inc., and Paratek Pharmaceuticals, Inc.
He was previously on the board of MAP Pharmaceuticals, Inc. Dr. Sun received his B.S.
in Electrical Engineering from Cornell University and his M.D. from Temple University School of Medicine with A.O.A. honors.
In addition, he is a Board Certified Internist and has an M.B.A. from The Wharton School at the University of Pennsylvania.
|
